Full text

Turn on search term navigation

© 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Declines in mitochondrial functions are associated with aging. The combination of 5‐aminolevulinic acid (5‐ALA) and sodium ferrous citrate (SFC) improves mitochondrial functions in cultured cells. In this study, we investigated the effects of dietary supplementation with 5‐ALA and SFC (5‐ALA/SFC) on the healthspan and life span of Drosophilamelanogaster. Adult Drosophila fruit flies were fed cornmeal food containing various concentrations of 5‐ALA/SFC. Locomotor functions, life span, muscle architecture, and age‐associated changes in mitochondrial function were analyzed. We found that feeding 5‐ALA/SFC mitigated age‐associated declines in locomotor functions and extended organismal life span. Moreover, 5‐ALA/SFC preserved muscle architecture and maintained the mitochondrial membrane potential in aged animals. Since 5‐ALA phosphate/SFC is used as a human dietary supplement, our results suggest that it could be used to slow the age‐related declines in muscle functions, prevent age‐associated clinical conditions such as frailty, and extend healthspan and life span.

Details

Title
5‐Aminolevulinic acid and sodium ferrous citrate ameliorate muscle aging and extend healthspan in Drosophila
Author
Nozawa, Naoko 1 ; Noguchi, Marie 2 ; Shinno, Kanako 2 ; Tajima, Maki 2 ; Aizawa, Shingo 2 ; Saito, Taro 3 ; Asada, Akiko 3 ; Ishii, Takuya 4 ; Ishizuka, Masahiro 4 ; Iijima, Koichi M 5 ; Ando, Kanae 3   VIAFID ORCID Logo 

 Graduate School of Science, Tokyo Metropolitan University, Japan; Division of Pharmaceutical Research, SBI Pharmaceuticals Co., Ltd., Tokyo, Japan 
 Graduate School of Science, Tokyo Metropolitan University, Japan 
 Graduate School of Science, Tokyo Metropolitan University, Japan; Department of Biological Sciences, School of Science, Tokyo Metropolitan University, Japan 
 Division of Pharmaceutical Research, SBI Pharmaceuticals Co., Ltd., Tokyo, Japan 
 Department of Neurogenetics, National Center for Geriatrics and Gerontology, Obu, Japan; Department of Experimental Gerontology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Japan 
Pages
295-305
Section
Research Articles
Publication year
2022
Publication date
Jan 2022
Publisher
John Wiley & Sons, Inc.
e-ISSN
22115463
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2616512312
Copyright
© 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.